Evercore ISI cuts Blackbaud stock price target on AI investments By Investing.com

Blackbaud reported Q1 revenue of $281.1 million, topping both Evercore ISI’s $279.9 million estimate and Street consensus of $279.8 million, while adjusted operating margin improved 120 bps to 29.6%. Adjusted free cash flow of $37.0 million beat Evercore’s estimate but missed Street expectations, and the company reaffirmed fiscal 2026 revenue guidance of $1.173 billion to $1.179 billion and free cash flow guidance of $280 million to $290 million. Management also highlighted planned AI investments and ongoing capital returns, including 1.6 million shares repurchased and $878 million remaining under authorization.

Analysis

The market is still underestimating the split signal in this print: Blackbaud is using margin and buybacks to defend EPS today while intentionally taking near-term EBITDA pressure to fund AI initiatives. That’s a classic rerating setup only if the AI spend actually expands retention or ARPU; otherwise it becomes a value trap where capital returns mask slowing core growth. The key question is not whether the company can keep buying back stock, but whether incremental AI investment creates a durable step-up in product stickiness over the next 4-6 quarters.

For competitors, the immediate winner is not another large-cap software peer but any smaller vertical SaaS name that can match Blackbaud’s pace of AI feature rollouts without sacrificing free cash flow. If Blackbaud’s AI spend improves workflow automation and customer-facing product quality, it raises the bar for nonprofit/education software vendors and could force a mini-capex arms race across the niche. If not, the spend simply compresses near-term margins while leaving the competitive moat unchanged, which is negative because the market tends to penalize “investment narratives” once growth fails to reaccelerate.

The buyback signal is supportive tactically, but it also caps upside in a weak operating environment: at this valuation, repurchases can buoy per-share metrics for 2-3 quarters, yet they cannot offset multiple compression if revenue growth stays in the mid-single digits. The most plausible reversal catalyst is any disappointment in retention or billings after the AI push, because that would expose the business as a low-growth cash generator rather than a compounding platform. Conversely, a surprise acceleration in organic recurring revenue above 6% would likely trigger a fast sentiment shift given how low expectations are set.

Consensus is probably too focused on the beat and not enough on the sequencing: management is effectively buying time with capital returns while asking investors to underwrite a 12-18 month product transition. That’s constructive only if you believe AI monetization shows up in customer metrics before the buyback firepower runs down. The better risk/reward is to own the stock only into confirmation of retention and ARR acceleration, not simply on headline EPS resilience.

Key Decisions for Investors

• Long BLKB only on a pullback toward the low-$40s, with a 6-12 month horizon; target a rerate toward $50+ only if retention and organic recurring revenue re-accelerate, otherwise use rallies to trim.
• Sell BLKB Jan-2026 or later calls against stock if already owned; the buyback can support downside but AI-led margin pressure likely keeps upside capped until execution is proven.
• Relative value: long high-quality vertical SaaS with proven AI monetization, short BLKB as a basket hedge over the next 2-4 quarters if you see stronger retention/ARR in peers; thesis is that capital returns are being used to bridge an execution gap.
• Avoid chasing BLKB on the earnings beat alone; wait for the next two quarters of customer metrics because the decisive catalyst is product adoption, not the current margin print.
• If BLKB trades above $50 without evidence of faster growth, consider reducing exposure; that level likely prices in an AI success scenario that is not yet validated.